Kristin Havranek has worked extensively with and in the MedTech industry for the last 25 years. A trusted advisor to investors and companies alike, Kristin regularly helps startup and emerging MedTech companies build their IP portfolios in a strategic, thoughtful manner with their business goals and needs in mind. She evaluates freedom-to-operate, patentability, investor due diligence and financing IP, and conducts patent validity analyses. She advises on strategic alliances and prepares and prosecutes patent applications before the US Patent and Trademark Office. Kristin was Chair of the Membership Committee for MedtechWomen in 2021-2022, and has served as Co-Chair of the Mentorship Committee for MedtechWomen 2022-2023.
Kristin’s background as a Biomedical engineer in industry, most recently as a Senior Engineer at Guidant Corporation, and as a MedTech attorney advising companies in a wide variety of technological areas makes her uniquely qualified to find the path to successful IP protection and value creation for your MedTech company.
Kristin has worked extensively in the medical device sector, including in the areas of stents, catheter systems, medical imaging, ophthalmic devices, orthopedics, diagnostics, drug delivery devices and systems, surgical devices, and orthodontics, as well as other mechanical and electromechanical systems and equipment in and outside the medical device field.
Prior to joining Goodwin, Kristin was most recently Senior Counsel at Wilson Sonsini. She was previously a Senior Engineer at Guidant Corporation.
While in law school, Kristin served as Articles Editor for Law Review.
Kristin serves as co-chair, membership for MedTechWomen.
University of San Francisco School of Law
University of Pennsylvania
- U.S. Patent and Trademark Office
Recognition & Awards
Kristin has been selected for inclusion in The Legal 500 US 2023.
Kristin was nominated by the Los Angeles Business Journal for their Women’s Leadership Award in 2022 and 2023.
- Co-Author, “Top 5 Compliance Issues for Medtech Firms Transitioning To Data-Enabled Solutions,” MedCity News, January 27, 2023
- Co-Author, “Top 5 FDA Considerations for Medtech-Enabled Data Platforms,” MedCity News, January 24, 2023
- Co-Author, “Top 5 IP Considerations for Medtech Companies Transitioning To Data-enabled Product Solutions,” MedCity News, January 20, 2023